The European Haemophilia Consortium has launched a five-part series of videos for patients and the general public to help them gain clarity and be more informed on key topics concerning gene therapy in haemophilia. The video series provides insights from both patient and expert points of view.
In part one of the series, Flora Peyvandi answers the fundamental question "What is gene therapy?". Paul Giangrande provides a short overview of gene therapy for haemophilia A and B in the second presentation of the series. The third instalment is presented by Dan Hart, who describes how a clinical trial in gene therapy for haemophilia works. In the penultimate video, Michael Makris explains the safety considerations for gene therapy. The final video in the series explores the patient's perspective of gene therapy with Jack Grehan.
Watch the video series here
In part one of the series, Flora Peyvandi answers the fundamental question "What is gene therapy?". Paul Giangrande provides a short overview of gene therapy for haemophilia A and B in the second presentation of the series. The third instalment is presented by Dan Hart, who describes how a clinical trial in gene therapy for haemophilia works. In the penultimate video, Michael Makris explains the safety considerations for gene therapy. The final video in the series explores the patient's perspective of gene therapy with Jack Grehan.
Watch the video series here